News

  • WHO launches framework to protect mothers and babies from extreme heat

    The World Health Organization (WHO) has launched a framework with the first set of priority indicators to track extreme heat risks for pregnant women, newborns and children. The indicators are intended to help countries monitor heat-related health impacts, improve preparedness and respond more quickly to rising temperatures. The launch follows growing evidence linking extreme heat [...]

  • US researchers awarded NIH funding for global maternal heart failure trial

    A global trial will test whether bromocriptine can reduce deaths and complications in women with pregnancy-related heart failure. The study focuses on peripartum cardiomyopathy (PPCM), a rare but life-threatening form of heart failure that develops towards the end of pregnancy or within five months of childbirth. The placebo-controlled trial will enrol approximately 650 women to [...]

  • Femasys partners with SandsRx Pharmacy to expand access to fertility treatment

    Femasys has partnered with SandsRx Pharmacy to support the launch of its FemaSeed fertility treatment in obstetrics and gynaecology practices. The agreement will provide specialist pharmacy support, coordinated access to fertility medications and preferred pricing for practices introducing the treatment. It is the first in a planned network of pharmacy partnerships supporting the rollout of [...]

  • Start-up seeks women’s views to shape next-gen breast health tech

    Dotplot and John Bell & Croyden are inviting women to attend breast health focus groups to help shape new technology. The femtech startup is developing a handheld device designed to make breast self-checks more consistent, helping women better understand their bodies and feel more confident about acting when something changes. The partnership aims to gather [...]

  • UK researchers secure £800k to investigate breast cancer recurrence using AI

    UK researchers have secured £800,000 to use AI to study breast cancer recurrence, focusing on why some oestrogen receptor-positive tumours return years after treatment. The funding will support two projects examining how cancer cells survive treatment, remain dormant and later begin growing again. Most breast cancers do not return after treatment, but some cells can [...]

  • AI and VR could improve access to menopause therapy, researchers say

    A new study suggests AI and VR could improve access to menopause therapy, although it has not shown whether the technology reduces symptoms. The multicentre study explored using artificial intelligence (AI) and virtual reality (VR) to deliver cognitive behavioural therapy (CBT) and other non-drug treatments for menopause symptoms. Researchers recruited women aged 45 to 60 [...]

  • AI-powered preconception platform Soonr named finalist in digital health awards

    Vespexx Inc., the AI femtech company behind Soonr, has been named a finalist in the Digital Health Hub Foundation Digital Health & AI Awards 2026 at HLTH, in the Rising Star track, Women’s & Family Health category. The company advanced from the Quarterfinalist stage announced in September. The Digital Health & AI Awards recognise organisations [...]

  • New study explores role of exercise in managing endometriosis pain

    An Australian trial will test whether yoga and walking can ease endometriosis pain, with more than 350 women already registering interest. The study will involve women aged 18 and over with medically diagnosed endometriosis who live in regional, rural and remote Australia. Participants will be randomly assigned to four groups: usual care, yoga alone, yoga [...]

  • NHS leader warns 20 maternity units may need to close

    Up to 20 maternity units in England may need to close or change their role to keep mothers and babies safe, an NHS leader has warned. Matthew Hopkins, the NHS Alliance’s director for acute care, told The Guardian that shortages of specialist doctors and rising caesarean section rates were making smaller maternity units increasingly difficult to sustain. [...]

  • Hormone tracking startup Unravel Health raises €2.96 million

    Unravel Health has raised €2.96m to develop a home hormone device designed to measure multiple hormones from a saliva sample in minutes. The London-based women’s health startup is developing the Micro Lab, a palm-sized device intended to allow women to monitor their hormone levels daily without laboratory visits. It is being designed to measure oestradiol, [...]